FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18353911000001107: Oprymea 0.18mg tablets (Krka UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jan 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2575121000001113 Oprymea 0.18mg tablets (Krka UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2575141000001115 Oprymea 0.18mg tablets (Krka UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oprymea 0.18mg tablets (Krka UK Ltd) Is a Pramipexole 180microgram tablets true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Is a Product containing precisely pramipexole dihydrochloride 180 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has active ingredient Pramipexole dihydrochloride false Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate false Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Is a Oprymea true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate true Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) Has basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Oprymea 0.18mg tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has AMP True Oprymea 0.18mg tablets (Krka UK Ltd) Inferred relationship Existential restriction modifier
Oprymea 0.18mg tablets (Krka UK Ltd) 100 tablet 10 x 10 tablets Has AMP True Oprymea 0.18mg tablets (Krka UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start